Insmed Stock News & Updates

[WKN: A1JJA3 | Symbol: INSM]

The Stock of Insmed Consolidates the Strong Q3 Results and is Poised for the Trend Continuation!

Insmed is a biopharmaceutical company focused on the development and marketing of therapies for patients...

5 Rising Biopharma Stocks with over 50% Annual Growth Potential

Dear readers, Last week, I introduced five biopharma stocks that have taken off in recent weeks. It...

Darvas Screening: CECO Environmental, Boot Barn Holdings, Oshkosh Corporation and Insmed.

The NEO-DARVAS STRATEGY is a remarkable trend-following approach based on a simple yet effective concept:...

Insmed – Biopharma Company Impresses With a Strong Pipeline, Positive Clinical Trial Data Leads to Stock Surge!

Business drivers: Insmed (INS) specializes in the development of medications and therapies for the treatment...

Relaxation in the Trade Dispute Between China and the USA Creates Positive Sentiment; Chip and Defense Stocks in Demand; Insmed Experiences Stock Fireworks After Positive Study Data!

The DAX is exhibiting a slight increase after a modest opening, up by 0.13% at the moment. A compromise...

Insmed Impresses With Study Data - TPIP Could Achieve Peak Revenue of $5.3 Billion and a Market Share of 40%!

Insmed (INSM) is regarded as a specialist in the treatment of rare and severe lung diseases and has already...

Stocks in Action USA: Plug Power, Casey's General Stores, Insmed

Plug Power (PLUG) CFO sends a strong signal – buying in the millions reinforces the growth strategy!...

Insmed: Specialist in Lung Diseases Aims to Increase Patient Reach by a Factor of 80 by 2030 - Brensocatib Represents an $8.2 Billion Opportunity!

The biotech company Insmed (INSM) specializes in the treatment of rare and severe lung diseases. The...

  • 1